Table 1.
Variable (Unit; Normal Range) | Baseline | Post Phase 1 | Post Phase 2 | Post Phase 3 |
---|---|---|---|---|
Weight (kg) | 92.1 | 92.7 | 93.7 | 95.3 |
Height (cm) | 166 | 166 | 166 | 166 |
BMI (kg/m2) | 33.43 | 33.65 | 34.01 | 34.59 |
ASMI (kg/m2) | 7.40 | 7.37 | 7.22 | 7.46 |
PBMC Count (106/mL; 0.5–3) | 3.1 * | 2.8 | 5.4 * | 4.4 * |
Lymphocytes (%; 22–44) | 32.53 | 45.20 * | 38.48 | 37.27 |
Monocytes (%; 3–10) | 12.69 * | 9.23 | 9.78 | 8.64 |
Monocytes (absolute counts; 109/L; 0–0.8) | 0.84 * | 0.53 | 0.58 | 0.53 |
CRP (mg/L; 0–5) | 14.00 * | 3.60 | 3.80 | 4 |
SII | 420.28 | 206.68 | 323.96 | 334.19 |
PLR | 123.61 | 88.33 | 111.71 | 107.46 |
MLR | 0.39 | 0.21 | 0.26 | 0.23 |
NLR | 1.57 | 0.91 | 1.31 | 1.36 |
Bilirubin (total; μmol/L; 1.7–18.9) | 7.9 | 6.4 | 5.7 | 6.6 |
Alkaline phosphatase (U/L; 42–98) | 68 | 60 | 68 | 62 |
ASMI: Appendicular skeletal muscle index; BMI: Body mass index; CRP: C-reactive protein; MLR: Monocyte to lymphocyte ratio; NLR: Neutrophil to lymphocyte ratio; PBMC: Peripheral blood mononuclear cells; PLR: Platelet to lymphocyte ratio; SII: Systemic Inflammation-Immune Index. * Values elevated than the upper limit of the normal range.